Newsroom

NHCAA Lens Spotlight - HHS-OIG Work Plan Updates

On June 15, 2017, the U.S. Department of Health and Human Services, Office of Inspector General (HHS-OIG) announced that it will now make monthly electronic updates to its Work Plan, making it more of a dynamic process that will allow the OIG to inform the public about the efforts and accomplishments of the office on a more real-time basis.

Read More

OIG finds CMS overpaid more than $729M in MU incentive payments

An HHS Office of Inspector General report revealed that nearly 12% of the total CMS incentive payments made for EHR incentive payments, or more than $729 million, were overpaid to eligible providers that did not meet meaningful use requirements. Officials advised the agency to try to recover the more than $700 million in inappropriate payments and the $2.3 million it overpaid to providers who switched from Medicaid to Medicare incentive programs.

Read More

Press Release: Nicholas J. Messuri, Esq., elected NHCAA Board Chair

The National Health Care Anti-Fraud Association (NHCAA) today announced that Nicholas J. Messuri, Esq., Vice President and Deputy General Counsel for Fraud Prevention & Recovery at DentaQuest and Delta Dental of Massachusetts has been elected as the new Chair of its Board of Directors. Messuri succeeds Katherine M. Leff, Director of the Special Investigations Unit (SIU) at CareSource.

Read More

Press Release: Kathy Leff Elected NHCAA Board Chair

The National Health Care Anti-Fraud Association (NHCAA) today announced that Katherine M. Leff, Director of the Special Investigations Unit (SIU) at CareSource has been elected as the new Chair of its Board of Directors. Leff succeeds Ralph Carpenter, Senior Director of the Special Investigations Unit (SIU) for Aetna.

Read More

Press Release: 2014 Investigation of the Year Award

The National Health Care Anti-Fraud Association (NHCAA) today presented its Investigation of the Year Award to a team of Federal agencies for their extraordinary work on the broad-reaching case of United States of America v. Johnson & Johnson / Janssen Pharmaceuticals.

Read More